Induction of cancerous stem cells during embryonic stem cell differentiation

Journal of Biological Chemistry

Volumn 287, Issue 44, 2012, Pages 36777-36791

  Fujimori, Hiroaki ^a,b   Shikanai, Mima ^b   Teraoka, Hirobumi ^b   Masutani, Mitsuko ^a   Yoshioka, Ken Ichi ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STEM CELLS; CELL DEVELOPMENT; CELL TRANSFORMATION; CELLULAR TRANSFORMATION; EMBRYONIC STEM CELLS; MUTATION INDUCTION; TUMORIGENESIS;

TISSUE CULTURE;

STEM CELLS;

BETA GALACTOSIDASE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL RENEWAL; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA DAMAGE; EMBRYONIC STEM CELL; ENZYME ACTIVITY; MOUSE; NEOPLASM; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CULTURE MEDIA; DNA DAMAGE; EMBRYONIC STEM CELLS; GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES; SPHEROIDS, CELLULAR; STRESS, PHYSIOLOGICAL; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84868227016     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.372557     Document Type: Article

References (49)

1. Wicha, M. S., Liu, S., and Dontu, G. (2006) Cancer stem cells. An old idea, a paradigm shift. Cancer Res. 66, 1883-1890
2. Werbowetski-Ogilvie, T. E., and Bhatia, M. (2008) Pluripotent human stem cell lines. What we can learn about cancer initiation. Trends Mol. Med. 14, 323-332
3. Chiba, T., Zheng, Y. W., Kita, K., Yokosuka, O., Saisho, H., Onodera, M., Miyoshi, H., Nakano, M., Zen, Y., Nakanuma, Y., Nakauchi, H., Iwama, A., and Taniguchi, H. (2007) Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 133, 937-950
4. Liu, Y., Clem, B., Zuba-Surma, E. K., El-Naggar, S., Telang, S., Jenson, A. B., Wang, Y., Shao, H., Ratajczak, M. Z., Chesney, J., and Dean, D. C. (2009) Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell 4, 336-347
5. Bartkova, J., Horejsí, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., Ørntoft, T., Lukas, J., and Bartek, J. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870
6. Gorgoulis, V. G., Vassiliou, L. V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R. A., Jr., Kastrinakis, N. G., Levy, B., Kletsas, D., Yoneta, A., Herlyn, M., Kittas, C., and Halazonetis, T. D. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913
7. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L. V., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., and Gorgoulis, V. G. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed byDNAdamage checkpoints. Nature 444, 633-637
8. Ichijima, Y., Yoshioka, K., Yoshioka, Y., Shinohe, K., Fujimori, H., Unno, J., Takagi, M., Goto, H., Inagaki, M., Mizutani, S., and Teraoka, H. (2010) DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PLoS One 5, e8821
9. Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., and Serrano, M. (2007) Delayed ageing through damage protection by the Arf/p53 pathway. Nature 448, 375-379
10. Sun, H., and Taneja, R. (2007) Analysis of transformation and tumorigenicity using mouse embryonic fibroblast cells. Methods Mol. Biol. 383, 303-310
11. Yang, Y. M., and Chang, J. W. (2008) Current status and issues in cancer stem cell study. Cancer Invest. 26, 741-755
12. Kim, J. H., Kim, S. H., Hahn, E. W., and Song, C. W. (1978) 5-Thio-Dglucose selectively potentiates hyperthermic killing of hypoxic tumor cells. Science 200, 206-207
13. Bunting, K. D. (2002) ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20, 11-20
14. Seaberg, R. M., and van der Kooy, D. (2003) Stem and progenitor cells. The premature desertion of rigorous definitions. Trends Neurosci. 26, 125-131
15. Leahy, A., Xiong, J. W., Kuhnert, F., and Stuhlmann, H. (1999) Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J. Exp. Zool. 284, 67-81
16. Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., and Beach, D. (2005) Glycolytic enzymes can modulate cellular life span. Cancer Res. 65, 177-185
17. Dontu, G., El-Ashry, D., and Wicha, M. S. (2004) Breast cancer, stem/progenitor cells, and the estrogen receptor. Trends Endocrinol. Metab. 15, 193-197
18. Jones, D. L., and Wagers, A. J. (2008) No place like home. Anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 9, 11-21
19. Knoepfler, P. S. (2009) Deconstructing stem cell tumorigenicity. A roadmap to safe regenerative medicine. Stem Cells 27, 1050-1056
20. Morange, M. (2006) What history tells us VII. Twenty-five years ago. The production of mouse embryonic stem cells. J. Biosci. 31, 537-541
21. Wylie, C. (1999) Germ cells. Cell 96, 165-174
22. Raaijmakers, M. H., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., Aung, Z., Matza, M., Merkenschlager, M., Lin, C., Rommens, J. M., and Scadden, D. T. (2010) Bone progenitor dysfunction induces myelodysplasia and secondary leukemia. Nature 464, 852-857
23. Smith, J. A., and Daniel, R. (2012) Stem cells and aging: a chicken-or-theegg issue? Aging Dis. 3, 260-268
24. Fujimori, H., Asahina, K., Shimizu-Saito, K., Ikeda, R., Tanaka, Y., Teramoto, K., Morita, I., and Teraoka, H. (2008) Vascular endothelial growth factor promotes proliferation and function of hepatocyte-like cells in embryoid bodies formed from mouse embryonic stem cells. J. Hepatol. 48, 962-973
25. Marusyk, A., Wheeler, L. J., Mathews, C. K., and DeGregori, J. (2007) p53 mediates senescence-like arrest induced by chronic replication stress. Mol. Cell. Biol. 27, 5336-5351
26. Fernandes, K. J., McKenzie, I. A., Mill, P., Smith, K. M., Akhavan, M., Barnabé-Heider, F., Biernaskie, J., Junek, A., Kobayashi, N. R., Toma, J. G., Kaplan, D. R., Labosky, P. A., Rafuse, V., Hui, C. C., and Miller, F. D. (2004) A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol. 6, 1082-1093
27. Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., and Hwang, E. S. (2006) Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 5, 187-195
28. Masaki, H., Nishida, T., Kitajima, S., Asahina, K., and Teraoka, H. (2007) Developmental pluripotency-associated 4 (DPPA4) localized in active chromatin inhibits mouse embryonic stem cell differentiation into a primitive ectoderm lineage. J. Biol. Chem. 282, 33034-33042
29. Nitou, M., Sugiyama, Y., Ishikawa, K., and Shiojiri, N. (2002) Purification of fetal mouse hepatoblasts by magnetic beads coated with monoclonal anti-e-cadherin antibodies and their in vitro culture. Exp. Cell Res. 279, 330-343
30. Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature 396, 643-649
31. Sherr, C. J., and McCormick, F. (2002) The RB and p53 pathways in cancer. Cancer Cell 2, 103-112]
32. Zhang, P., Andrianakos, R., Yang, Y., Liu, C., and Lu, W. (2010) Kruppellike factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J. Biol. Chem. 285, 9180-9189
33. Jain, A. K., Allton, K., Iacovino, M., Mahen, E., Milczarek, R. J., Zwaka, T. P., Kyba, M., and Barton, M. C. (2012) p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol. 10, e1001268
34. Ferrandina, G., Petrillo, M., Bonanno, G., and Scambia, G. (2009) Targeting CD133 antigen in cancer. Expert Opin. Ther. Targets 13, 823-837
35. Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
36. Spierings, D. C., de Vries, E. G., Vellenga, E., and de Jong, S. (2003) The attractive Achilles heel of germ cell tumors. An inherent sensitivity to apoptosis-inducing stimuli. J. Pathol. 200, 137-148
37. Oh, S. K., and Choo, A. B. (2006) Human embryonic stem cells. Technological challenges toward therapy. Clin. Exp. Pharmacol. Physiol. 33, 489-495
38. Atsumi, Y., Fujimori, H., Fukuda, H., Inase, A., Shinohe, K., Yoshioka, Y., Shikanai, M., Ichijima, Y., Unno, J., Mizutani, S., Tsuchiya, N., Hippo, Y., Nakagama, H., Masutani, M., Teraoka, H., and Yoshioka, K. (2011) Onset of quiescence following p53-mediated down-regulation of H2AX in normal cells. PLoS One 6, e23432
39. Yoshioka, K., Atsumi, Y., Fukuda, H., Masutani, M., and Teraoka, H. (2012) The quiescent cellular state is Arf/p53-dependent and associated with H2AX down-regulation and genome stability. Int. J. Mol. Sci. 13, 6492-6506
40. Celeste, A., Difilippantonio, S., Difilippantonio, M. J., Fernandez-Capetillo, O., Pilch, D. R., Sedelnikova, O. A., Eckhaus, M., Ried, T., Bonner, W. M., and Nussenzweig, A. (2003) H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114, 371-383
41. Woo, R. A., and Poon, R. Y. (2004) Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev. 18, 1317-1330
42. Deckbar, D., Birraux, J., Krempler, A., Tchouandong, L., Beucher, A., Walker, S., Stiff, T., Jeggo, P., and Löbrich, M. (2007) Chromosome breakage after G2 checkpoint release. J. Cell Biol. 176, 749-755
43. Oh, S. J., Erb, H. H., Hobisch, A., Santer, F. R., and Culig, Z. (2012) Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways. Endocr. Relat. Cancer 19, 305-319
44. Mitsiades, C. S., Mitsiades, N., and Koutsilieris, M. (2004) The Akt pathway. Molecular targets for anti-cancer drug development. Curr. Cancer Drug Targets 4, 235-256
45. Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., Ashworth, A., Carmichael, J., Kaye, S. B., Schellens, J. H., and de Bono, J. S. (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 361, 123-134
46. Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., and Campisi, J. (2003) Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5, 741-747
47. Wiles, M. V., and Keller, G. (1991) Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 111, 259-267
48. Guachalla, L. M., and Rudolph, K. L. (2010) ROS induced DNA damage and checkpoint responses. Influences on aging? Cell Cycle 9, 4058-4060
49. Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., and Weissman, I. L. (2007) Deficiencies in DNA damage repair limit the function of hematopoietic stem cells with age. Nature 447, 725-729